Ezisurg Medical Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ezisurg Medical Co., Ltd. - overview
Established
2011
Location
Shanghai, -, China
Primary Industry
Medical Devices & Equipment
About
Established in 2011 and based in Shanghai, China, Ezisurg Medical Co. , Ltd. is a medical technology company that provides minimally invasive products. The subsidiaries have been set up in the United States and the Netherlands.
The company has acquired 55 global certifications including 7 FDA approvals and 14 CE marks. In August 2020, it closed a series C funding. In 2022, the disposable cyst pelvic endoscopy system acquired NMPA registration. The company is committed to providing minimally invasive surgical medical devices for tumors.
The products can be categorized into luminal anastomosis series, ultrasonic knife products, and optical imaging products, which have been used in more than 1,000 hospitals across China, of which Grade 3A hospitals account for more than 40%.
Current Investors
Shanghai Pudong Hi-tech Investment, Xiamen C&D Group, BioTrack Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Surgical Devices
Website
www.ezisurg.com
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.